Articles by Control, a senior compliance officer - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Control, a senior compliance officer

Who's Inspecting the Inspectors?

Even the most well-planned inspections can meet with mishaps.
Sep 2, 2006

Apparently, the inspector would sneak off to visit his relatives on FDA time, instead of visiting us.

Our Readers Write In

Aug 2, 2006

Thanks to you, we have this month's column. Keep those cards, letters, and e-mails coming.

Water, Water Everywhere

Working with water means you sometimes have to deal with drips.
Jul 2, 2006

My audit host clearly knew and lied about the planned changes.

The Fine Print

Check your labels carefully. Shortcuts, bargains, and one-word errors can wind up costing you down the line.
Jun 2, 2006

I always suspected that our purchasing manager had agreed to this just to save money . . .

Of Mice and Money

May 2, 2006

Animal testing and accounting can both be hazardous.

On the Bright Side

Apr 2, 2006

Vitamin D and a sunny window shed som light on product stability.

Mysteries and Mishaps

Mar 2, 2006

Madness in March: lost ingredients, missed lot numbers, and a million-dollar photo.

Sweet Mix-ups and Sour Data

Feb 2, 2006

"It was the late 1970s," reports our GMP-Agent-in-Place, "and we used a primitive desktop computer with built-in teletype for our quality control work.

Oil, Water, and Kicks

Jan 1, 2006

A particular dermatological product was packaged in a metal tube, which is filled from the bottom.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
23%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
7%
All of the above.
47%
No government involvement in patient treatment or drug development.
9%
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
FindPharma Custom Search
Click here